Latest News Archive

Please select Category, Year, and then Month to display items

Status of the UFS 2019 registration process

11 January 2019 | Story Lacea Loader

Status of the UFS 2019 registration process

The on-campus registration process at the University of the Free State (UFS) has not yet commenced. Although the online registration process started on 7 January 2019, the on-campus registration process on the university’s Bloemfontein and Qwaqwa Campuses will commence on 21 January 2019.

Some media reports that the registration process commenced this week and that registration points on the Bloemfontein Campus have been shut down by a number of students, are untrue. The only student academic services currently available on the campus are that of information services and enquiries from students visiting faculties, as well as assistance with online access to the Central Application Clearing House (CACH).

A group of students under the banner of the SASCO Bloemfontein Branch, and operating without engaging with the university’s existing student structures, disrupted student academic services on the Bloemfontein Campus and blocked entrance to the campus at one of the five gates on Wednesday 9 January 2019, indicating that the university management has not effectively dealt with some student-related matters pertaining to the 2019 registration process. The on-campus student academic services programme was subsequently temporarily suspended. However, online and email academic services continued as normal.

Following Wednesday’s disruption, the executive management of the UFS engaged with the group of students who disrupted the student academic services programme, as well as with representatives of the Institutional Student Representative Council (ISRC). Concessions between the university and the ISRC were reached yesterday.

The executive management expressed its appreciation for the ISRC’s cooperation and for its commitment towards student access to higher education. As the legitimate statutory body representing students, the ISRC will work with the management to ensure that preparations for the upcoming registration process run smoothly. The management furthermore condemned the behaviour of the group of students who disrupted the student academic services programme.

The registration process on the Bloemfontein and Qwaqwa Campuses will commence on 21 January 2019 when senior students requiring assistance or academic advice, will be assisted on the campuses. The registration process and academic advising services for first-time entering, first-year students start according to a set schedule from 25 January 2019 on the Bloemfontein Campus, and from 28 January 2019 on the Qwaqwa Campus.

Enquiries regarding registration can be directed to the university’s Call Centre at 051 401 9666. Detailed information about the 2019 registration process is available at www.ufs.ac.za

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children

2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept